A Phase II/III Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Condition:   Inclusion Body Myositis Intervention:   Drug: ABC008 Sponsors:   Abcuro, Inc.;   Syneos Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials